[1]王 宏,安 莹,闫铁静,等.降脂消胰汤内服与灌肠联合西药治疗高脂血症性胰腺炎疗效及对患者血脂、凝血功能的影响[J].陕西中医,2024,(6):785-788.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.013]
　WANG Hong,AN Ying,YAN Tiejing,et al.Effects of oral and enema administration of Jiangzhi Xiaoyi decoction combined with western medicine on blood lipid levels,coagulation function in patients with hyperlipidemic pancreatitis[J].,2024,(6):785-788.[doi:DOI:10.3969/j.issn.1000-7369.2024.06.013]
点击复制

降脂消胰汤内服与灌肠联合西药治疗高脂血症性胰腺炎疗效及对患者血脂、凝血功能的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年6期
页码:
785-788
栏目:
临床研究
出版日期:
2024-06-05

文章信息/Info

Title:
Effects of oral and enema administration of Jiangzhi Xiaoyi decoction combined with western medicine on blood lipid levels,coagulation function in patients with hyperlipidemic pancreatitis
作者:
王 宏; 安 莹; 闫铁静; 陆 勇; 王海涛
(秦皇岛市中医医院,河北 秦皇岛 066000)
Author(s):
WANG Hong; AN Ying; YAN Tiejing; LU Yong; WANG Haitao
(Qinhuangdao Hospital of Traditional Chinese Medicine,Qinhuangdao 066000,China)
关键词:
高脂血症性胰腺炎;  降脂消胰汤;  灌肠;  总胆固醇;  甘油三酯;  凝血功能
Keywords:
Hyperlipidemic pancreatitis;  Jiangzhi Xiaoyi decoction;  Enema;  Total cholesterol;  Triglycerides;  Coagulation function
分类号:
R 657.51
DOI:
DOI:10.3969/j.issn.1000-7369.2024.06.013
文献标志码:
A
摘要:
目的:研究降脂消胰汤内服与灌肠联合西药治疗对高脂血症性胰腺炎(HLP)患者血脂水平、凝血功能及预后的影响。方法:选取128例HLP患者,按随机数字表法分为两组,中医组64例,对照组61例(随访过程脱落3例)。对照组采用常规西药治疗,中医组在此基础上采用降脂消胰汤内服和灌肠治疗,比较两组患者临床疗效、血脂水平、凝血功能和预后情况。结果:中医组HLP患者治疗总有效率为95.31%,高于对照组的83.61%(P<0.05)。治疗后,中医组总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL)低于对照组,高密度脂蛋白(HDL)高于对照组(P<0.05)。治疗后,中医组血管性血友病因子(vWF)、凝血酶原时间(PT)、纤维蛋白原(FIB)、D-二聚体(D-dimer)均低于对照组(P<0.05)。中医组禁食禁水时间、住院总时间均短于对照组,SAP转化率低于对照组(P<0.05)。结论:降脂消胰汤内服与灌肠联合西医治疗HLP可提高患者临床疗效,有效改善血脂水平和凝血功能。
Abstract:
Objective:To study the effects of oral and enema administration of Jiangzhi Xiaoyi decoction combined with western medicine treatment on blood lipid levels,coagulation function and prognosis in patients with hyperlipidemic pancreatitis(HLP).Methods:A total of 128 patients with HLP were selected,and randomly divided into the TCM group(64 cases)and the control group(61 cases)after excluding 3 cases lost to follow up.Patients in the control group were given conventional western medicine treatment.On this basis,patients in the TCM group were given oral and enema administration of Jiangzhi Xiaoyi decoction.Therapeutic effects,blood lipid levels,coagulation function and prognosis were compared between the two groups.Results:The total effective rate of treatment in the TCM group was higher than that in the control group(P<0.05).After treatment,the levels of total cholesterol(TC),triglycerides(TG)and low-density lipoprotein(LDL)in the TCM group were lower than those in the control group.The level of high-density lipoprotein(HDL)in the TCM group was higher than that in the control group(P<0.05).After treatment,the levels of von Willebrand Factor(vWF),prothrombin time(PT),fibrinogen(FIB)and D-dimer in the TCM group were lower than those in the control group(P<0.05).The duration of fasting for solids and liquids and length of hospital stay in the TCM group were shorter than those in the control group.The SAP conversion rate in the TCM group was lower than that in the control group(P<0.05).Conclusion:Oral and enema administration of Jiangzhi Xiaoyi decoction combined with western medicine treatment can improve the therapeutic effect on HLP,effectively improve blood lipid levels and coagulation function.

参考文献/References:

[1] 刘康,田道.胸段硬膜外阻滞治疗急性重症胰腺炎疗效及对患者肾功能的影响[J].陕西医学杂志,2022,51(7):839-842.
[2] 杜娟娟,李增晖,刘威,等.急性胰腺炎病程的动态变化及影像学评价[J].国际医学放射学杂志,2021,44(3):303-309.
[3] 蒋鑫,严永峰,钟瑞,等.胆源性急性胰腺炎与高甘油三酯血症性急性胰腺炎临床特点对比分析[J].临床肝胆病杂志,2020,36(9):2050-2055.
[4] 姜景平,盛锦义,方聪.不同程度高甘油三酯血症对于急性胰腺炎病情严重性的影响[J].世界华人消化杂志,2020,28(15):730-734.
[5] 崔沪宁,梅超鹏,崔梦巍,等.血氯和IL-6联合凝血指标对重症急性胰腺炎严重程度的预测价值[J].中华危重病急救医学,2022,34(12):1301-1304.
[6] 潘龙飞,裴红红,宏欣,等.高甘油三酯血症性急性胰腺炎的诊治[J].实用医学杂志,2021,37(20):2569-2574.
[7] YANG C,WANG T,CHEN J,et al.Traditional Chinese medicine formulas alleviate acute pancreatitis:Pharmacological activities and mechanisms[J].Pancreas,2021,50(10):1348-1356.
[8] 中华医学会外科学分会胰腺外科学组.中国急性胰腺炎诊治指南(2021)[J].中华消化外科杂志,2021,20(7):730-739.
[9] 中华中医药学会脾胃病分会.急性胰腺炎中医诊疗专家共识意见(2017)[J].临床肝胆病杂志,2017,33(11):2052-2057.
[10] 刘畅,宋建梅,李晓阳.NLR、PLR在高血脂症性急性胰腺炎诊断及病情评估中的价值[J].分子诊断与治疗杂志,2021,13(3):380-383,387.
[11] 赵丽,裴红红,白郑海,等.血清微小RNA-21-3p及白细胞介素-18水平对急性重症胰腺炎并发急性肾损伤的预测价值[J].陕西医学杂志,2023,52(6):705-708,713.
[12] 杨小妹,马康康,高俊茶.PCSK9与高脂血症性胰腺炎相关性机制探讨[J].现代消化及介入诊疗,2022,27(3):395-398.
[13] XIA W,LU Z,CHEN W,et al.Excess fatty acids induce pancreatic acinar cell pyroptosis through macrophage M1 polarization[J].BMC Gastroenterol,2022,22(1):72.
[14] LIN Y F,YAO Y,XU Y,et al.Apheresis technique for acute hyperlipidemic pancreatitis:A systemic review and meta-analysis[J].Dig Dis Sci,2023,68(3):948-956.
[15] WU Z,WANG X,JIANG X.Study on the mechanism of probucol nanosuspension on hyperlipidemic pancreatitis and regulation of blood lipid function[J].J Nanosci Nanotechnol,2021,21(2):1286-1292.
[16] LIU G,LIU F,XIAO L,et al.Narrative review of the mechanisms of action of dachengqi decoction in the treatment of hyperlipidemic pancreatitis on six-hollow-organs to be unblocked theory[J].Ann Palliat Med,2020,9(4):2323-2329.
[17] 姜盛楠,张红,支文冰,等.基于“一气周流”理论探讨慢性胰腺炎病机与治则[J].陕西中医,2022,43(9):1260-1262.
[18] 严佳,凌琪华,方荣,等.中药灌肠治疗急性胰腺炎用药规律研究[J].中国中医急症,2023,32(1):7-10,19.
[19] 潘华,叶文冲,戴家超,等.通腑解毒方联合大承气汤保留灌肠和常规治疗对急性胰腺炎患者的临床疗效[J].中成药,2022,44(3):776-780.
[20] LE J,JI H,ZHOU X,et al.Pharmacology,toxicology,and metabolism of sennoside A,a medicinal plant-derived natural compound [J].Front Pharmacol,2021,12:714586.
[21] 王少平,于盈盈,宋晓光,等.柴胡总皂苷降血脂作用及机制研究[J].中国新药杂志,2020,29(4):437-442.
[22] 刘亚洲,姜静雨,拉毛才旦,等.大黄的降血脂生物活性成分及作用机制研究进展[J].食品安全质量检测学报,2023,14(11):272-282.
[23] 苟园园,姚隆,曹洁.高甘油三酯血症性急性胰腺炎凝血指标与D-二聚体水平变化及其预测疾病严重程度的价值[J].中南大学学报(医学版),2023,48(7):1050-1058.
[24] 李勤,刘超男,凌莉琴,等.凝血相关的实验室指标对急性胰腺炎患者的病情和预后有较高预测价值[J].南方医科大学学报,2022,42(7):1006-1012.
[25] 尹诗,谢安卫,肖敬鄂,等.二草清胰汤内服及保留灌肠联合乌司他丁治疗急性胰腺炎临床研究[J].陕西中医,2023,44(2):183-186,190.
[26] 张利.丹参酮ⅡA磺酸钠联合乌司他丁对重症急性胰腺炎患者炎症及血管内皮功能的影响[J].河北医药,2016,38(19):2923-2926.

备注/Memo

备注/Memo:
基金项目:河北省中医药管理局科研课题(2022537); 河北省秦皇岛市科学技术研究与发展计划项目(202101A061)
更新日期/Last Update: 2024-06-11